Ralph del Campo

2008

In 2008, Ralph del Campo earned a total compensation of $1.3M as Chief Operating Officer and Principal Executive Officer at Enzon Pharmaceuticals, a 6% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$320,000
Salary$412,263
Stock Awards$512,600
Other$33,184
Total$1,278,046

del Campo received $512.6K in stock awards, accounting for 40% of the total pay in 2008.

del Campo also received $320K in non-equity incentive plan, $412.3K in salary and $33.2K in other compensation.

Rankings

In 2008, Ralph del Campo's compensation ranked 3,647th out of 9,135 executives tracked by ExecPay. In other words, del Campo earned more than 60.1% of executives.

ClassificationRankingPercentile
All
3,647
out of 9,135
60th
Division
Manufacturing
1,307
out of 3,436
62nd
Major group
Chemicals And Allied Products
243
out of 815
70th
Industry group
Drugs
140
out of 597
77th
Industry
Biological Products, Except Diagnostic Substances
24
out of 118
80th
Source: SEC filing on April 8, 2011.

del Campo's colleagues

We found five more compensation records of executives who worked with Ralph del Campo at Enzon Pharmaceuticals in 2008.

2008

Jeffrey Buchalter

Enzon Pharmaceuticals

Chief Executive Officer

2008

Craig Tooman

Enzon Pharmaceuticals

Chief Financial Officer

2008

Ivan Horak

Enzon Pharmaceuticals

Chief Scientific Officer

2008

Paul Davit

Enzon Pharmaceuticals

Executive Vice President, Human Resources and Administration

2008

Mark Ogden

Enzon Pharmaceuticals

Acting Vice President, Finance and Principal Financial Officer

You may also like